| Name | TAK-070 |
|---|
| Description | TAK-070 Free base is a noncompetitive and orally active BACE1 inhibitor (IC50: 3.15 μM). TAK-070 Free base can be used for research of Alzheimer’s disease (AD). TAK-070 Free base inhibits brain levels of soluble Aβ, and improves cognitive impairments in AD model[1]. |
|---|---|
| Related Catalog | |
| Target |
3.15 μM (BACE1)[1]. |
| References |
| Density | 1.058±0.06 g/cm3(Predicted) |
|---|---|
| Boiling Point | 534.8±50.0 °C(Predicted) |
| Molecular Formula | C27H31NO |
| Molecular Weight | 385.54 |